Tezepelumab Reduces Rate of COPD Exacerbations in Individuals with Wide Range of Blood Eosinophil Levels: Phase 2a COURSE Trial Findings
ATS: The biologic shows promise in a range of people with COPD, particularly those with BEC levels of 150 cells/μL and greater, according to findings released at the 2024 ATS meeting.
ETHOS Post-Hoc Analysis: Dave Singh, MD, Highlights Breztri Reduction of Cardiopulmonary Risk in COPD
The triple therapy cut risk of a first cardiopulmonary event by 20% vs dual therapy in addition to significantly reducing COPD exacerbations, PI Singh told Patient Care.
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women
Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.
Vaping, Drinking Before Pregnancy Not Tied to Higher Risk of Miscarriage: Daily Dose
Your daily dose of the clinical news you may have missed.
Menopausal VMS Severity, Frequency Reduced Significantly with Elinzanetant: Bayer Shares Data from Pivotal OASIS 1 and 2 Trials
The 2 phase 3 trials met all primary and secondary endpoints, showing statistically significant reduction in symptoms and sleep disturbance and improvement in quality of life.
Roche Says Investigational Once-Weekly "Twincretin" Shows Promise in Adults with Obesity in Early Stage Clinical Trial
In the phase 1b trial, treatment with once-weekly subcutaneous CT-388 led to a statistically significant mean placebo-adjusted weight loss of nearly 20%.
Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose
AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons
Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.
Lilly's Once-A-Week Insulin Demonstrates Safety, HbA1c Lowering Consistent with Daily Insulin
Safety and HbA1c reduction with efsitora alfa dosed once weekly was comparable to both daily insulin degludec and daily insulin glargine, announced Lilly.
Irregular Menstrual Cycle Associated with Cardiometabolic Conditions in Women Regardless of PCOS Status
New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.
HRSA Women's Preventive Health Services Guidelines: A Topline Look
Get a quick overview of recommendations for preventive health services and screenings focused on the unique needs of women across the lifespan.
SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose
May Issue of Patient Care Online Digital Edition is Now Live
Find details on a novel web tool found to help patients determine their eligibility for OTC statin use, FDA clearance of the first AI-based algorithm to detect HF during routine exams, and more.
Colorectal Cancer Rates Significantly Rising among Younger Adults and Teens, According to New Research
DDW 24. Among patients aged 15 to 19 years, the incidence of CRC rose 333% over a 22-year period, researchers reported.
Teal Health Granted Breakthrough Device Designation for Self-Collect Cervical Cancer Screening Device
FDA Approves Novel Noninvasive Multitarget Stool RNA CRC Screening Test: Daily Dose
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
Use of Most Contraceptive Methods Decreased from 2019-2022: Daily Dose
Hip Pain in a Man with Type 1 Diabetes: Seen in the ED
Patient is in his forties; pain has been waxing, waning, worsening for 2 weeks. He has no other significant medical history. Do lab results hold clues? What's your Dx?
Pilot Referral Program May Help Increase Postpartum Visits to Primary Care Clinicians
Women referred from obstetrics to primary care postpartum via a pilot program were more likely to attend a PCP visit than nonreferred women.
